X4 Pharmaceuticals
XFOR3.9402.34% ( +0.090 )
X4 Pharmaceuticals (XFOR)
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of ra...
- Open
- 3.860
- High
- 3.995
- Low
- 3.830
- Prev. Close
- 3.850
- Volume
- 360.03K
- Turnover
- 1.41M
- Avg Price
- 3.926
- Bid/Ask Ratio
- --
- Amplitude
- 4.29%
- 52wk High
- 4.830
- Volume Ratio
- 0.60
- Turnover Ratio
- 0.63%
X4 Pharmaceuticals Analyst Rating
View MoreForecast & Rating
Jul 10, 2026Price forecast
$11.60194.42%
Forecast & RatingStrong buy
5analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 2 days ago, 03:29 AM
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Receives Average Rating of "Moderate Buy" from Analysts
- CoinLive · Jul 10 at 07:33 AM
Wall Street analyst calls: DA Davidson starts AGCO at buy; Citi cuts Pepsi to neutral; Wells Fargo upgrades Seagate
- Unusual Whales · Jul 7 at 03:32 PM
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PUBT · Jul 7 at 03:30 PM
X4 Pharmaceuticals issues inducement stock options for 750,000 shares at $4.03 each
- Tip Ranks · Jul 1 at 09:05 PM
CFO’s Bold Move at X4 Pharmaceuticals Shakes Up Investor Buzz
- PUBT · Jul 1 at 06:01 AM
X4 Pharmaceuticals appoints CAMP4 CFO Kelly Gold to board, audit committee
